Lixte Biotechnology (LIXT) Q3 2023 Earnings

9NovConfirmed
Nov 22
Q4 2022
Q2 2023
Q3 2023
-1
-0.7
-0.39
-0.09

Details

Expected EPS
N/A
Actual EPS
-0.49
Surprise EPS
-0.49
Surprise Percent
+∞%

Description

Lixte Biotechnology (LIXT) has reported earnings of -0.49 per share for Q3 2023.

0 Comments

Share your thoughts